HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 7, Pages 3699-3716
Publisher
American Society for Clinical Investigation
Online
2020-04-22
DOI
10.1172/jci129049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical genomics reveals histone deacetylases are required for core regulatory transcription
- (2019) Berkley E. Gryder et al. Nature Communications
- Glioma Stem Cell Specific Super Enhancer Promotes Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling
- (2019) Ryan C Gimple et al. Cancer Discovery
- Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors
- (2019) Trang Thi Thu Nguyen et al. Cancers
- MYC-induced metabolic stress and tumorigenesis
- (2018) Adam J. Wolpaw et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Fenofibrate prevents skeletal muscle loss in mice with lung cancer
- (2018) Marcus D. Goncalves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma
- (2018) Richard Mair et al. CANCER RESEARCH
- Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
- (2017) Georg Karpel-Massler et al. Expert Opinion on Drug Discovery
- Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
- (2017) Sharanya Sivanand et al. MOLECULAR CELL
- Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
- (2017) Stephen C. Mack et al. NATURE
- Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers
- (2017) Gilson J Sanchez et al. NUCLEIC ACIDS RESEARCH
- Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
- (2017) Georg Karpel-Massler et al. Nature Communications
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Advances in epigenetic glioblastoma therapy
- (2017) Dong Hoon Lee et al. Oncotarget
- PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
- (2017) Boxi Zhang et al. Cell Reports
- Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
- (2016) Dan Y. Gui et al. Cell Metabolism
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Dual modulation of MCL-1 and mTOR determines the response to sunitinib
- (2016) Mohamed Elgendy et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Reductive carboxylation supports redox homeostasis during anchorage-independent growth
- (2016) Lei Jiang et al. NATURE
- A PGC1α-mediated transcriptional axis suppresses melanoma metastasis
- (2016) Chi Luo et al. NATURE
- A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
- (2016) Michael E Pacold et al. Nature Chemical Biology
- FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
- (2016) J Tong et al. ONCOGENE
- Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities
- (2016) Jorge Franco et al. Cell Reports
- MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
- (2015) Patricia Sancho et al. Cell Metabolism
- Acetyl Coenzyme A: A Central Metabolite and Second Messenger
- (2015) Federico Pietrocola et al. Cell Metabolism
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer
- (2015) Anthony C. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
- (2013) Francisca Vazquez et al. CANCER CELL
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
- (2013) Kenta Masui et al. Cell Metabolism
- Pan-Mammalian Target of Rapamycin (mTOR) Inhibitor AZD8055 Primes Rhabdomyosarcoma Cells for ABT-737-induced Apoptosis by Down-regulating Mcl-1 Protein
- (2013) Ellen Preuss et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
- (2012) M. Lemoine et al. BLOOD
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
- (2011) Jason W Locasale et al. NATURE GENETICS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes
- (2010) Diego Pasini et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now